Structure

Physi-Chem Properties

Molecular Weight:  454.31
Volume:  497.893
LogP:  4.85
LogD:  3.651
LogS:  -4.62
# Rotatable Bonds:  5
TPSA:  71.44
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.488
Synthetic Accessibility Score:  5.157
Fsp3:  0.759
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.256
MDCK Permeability:  1.3704727280128282e-05
Pgp-inhibitor:  0.566
Pgp-substrate:  0.013
Human Intestinal Absorption (HIA):  0.011
20% Bioavailability (F20%):  0.87
30% Bioavailability (F30%):  0.797

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.519
Plasma Protein Binding (PPB):  94.17974090576172%
Volume Distribution (VD):  0.876
Pgp-substrate:  1.8843207359313965%

ADMET: Metabolism

CYP1A2-inhibitor:  0.017
CYP1A2-substrate:  0.469
CYP2C19-inhibitor:  0.019
CYP2C19-substrate:  0.901
CYP2C9-inhibitor:  0.155
CYP2C9-substrate:  0.468
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.441
CYP3A4-inhibitor:  0.294
CYP3A4-substrate:  0.316

ADMET: Excretion

Clearance (CL):  7.236
Half-life (T1/2):  0.369

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  0.399
Drug-inuced Liver Injury (DILI):  0.579
AMES Toxicity:  0.005
Rat Oral Acute Toxicity:  0.966
Maximum Recommended Daily Dose:  0.086
Skin Sensitization:  0.097
Carcinogencity:  0.226
Eye Corrosion:  0.1
Eye Irritation:  0.019
Respiratory Toxicity:  0.598

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470015

Natural Product ID:  NPC470015
Common Name*:   Antcin A
IUPAC Name:   (6R)-2-methyl-3-methylidene-6-[(4S,5S,10S,13R,14R,17R)-4,10,13-trimethyl-3,11-dioxo-2,4,5,6,7,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid
Synonyms:   Antcin A
Standard InCHIKey:  WTSUWKBKPMVEBO-QMHPZZQYSA-N
Standard InCHI:  InChI=1S/C29H42O4/c1-16(18(3)27(32)33)7-8-17(2)21-11-12-23-20-9-10-22-19(4)24(30)13-14-28(22,5)26(20)25(31)15-29(21,23)6/h17-19,21-23H,1,7-15H2,2-6H3,(H,32,33)/t17-,18?,19+,21-,22+,23+,28+,29-/m1/s1
SMILES:  CC(C(=C)CC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC(=O)C1=C2CC[C@@H]2[C@]1(C)CCC(=O)[C@H]2C)C)C(=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1644793
PubChem CID:   10004121
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0003567] Ergostane steroids
          • [CHEMONTID:0001403] Ergosterols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30573 Antrodia camphorata Species Fomitopsidaceae Eukaryota n.a. n.a. n.a. PMID[14738384]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota n.a. fruit body n.a. PMID[15095145]
NPO30573 Antrodia camphorata Species Fomitopsidaceae Eukaryota fruiting bodies n.a. n.a. PMID[16643055]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota n.a. n.a. n.a. PMID[17559265]
NPO30573 Antrodia camphorata Species Fomitopsidaceae Eukaryota n.a. n.a. n.a. PMID[17559265]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota n.a. mycelium n.a. PMID[17932820]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota n.a. fruit body n.a. PMID[21028898]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota fruiting body n.a. n.a. PMID[21028898]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota fruiting body n.a. n.a. PMID[21115251]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota n.a. n.a. n.a. PMID[23517145]
NPO30573 Antrodia camphorata Species Fomitopsidaceae Eukaryota n.a. n.a. n.a. PMID[24387703]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota n.a. n.a. n.a. PMID[31891260]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota n.a. fruit body n.a. PMID[8594142]
NPO30573 Antrodia camphorata Species Fomitopsidaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14403 Taiwanofungus camphoratus Species Coriolaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT270 Individual Protein Nitric oxide synthase, inducible Mus musculus IC50 = 4100.0 nM PMID[508174]
NPT1184 Cell Line Daoy Homo sapiens ED50 = 13.2 ug ml-1 PMID[508174]
NPT83 Cell Line MCF7 Homo sapiens ED50 = 13.3 ug ml-1 PMID[508174]
NPT1171 Cell Line HEp-2 Homo sapiens ED50 > 20.0 ug ml-1 PMID[508174]
NPT165 Cell Line HeLa Homo sapiens ED50 > 20.0 ug ml-1 PMID[508174]
NPT91 Cell Line KB Homo sapiens EC50 = 4900.0 nM PMID[508175]
NPT34 Cell Line BV-2 Mus musculus IC50 = 4100.0 nM PMID[508175]
NPT34 Cell Line BV-2 Mus musculus IC50 = 45900.0 nM PMID[508175]
NPT81 Cell Line A549 Homo sapiens IC50 = 39400.0 nM PMID[508176]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 29600.0 nM PMID[508176]
NPT2 Others Unspecified IC50 = 29200.0 nM PMID[508174]
NPT2 Others Unspecified IC50 = 45900.0 nM PMID[508174]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. EC50 = 10000.0 nM PMID[508175]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 29200.0 nM PMID[508175]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470015 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC168188
0.9747 High Similarity NPC311702
0.9747 High Similarity NPC123319
0.9747 High Similarity NPC94531
0.9367 High Similarity NPC320514
0.9367 High Similarity NPC327969
0.9367 High Similarity NPC321289
0.9367 High Similarity NPC260956
0.9241 High Similarity NPC38350
0.9241 High Similarity NPC477372
0.9241 High Similarity NPC201912
0.9136 High Similarity NPC320801
0.9136 High Similarity NPC209882
0.9036 High Similarity NPC136948
0.9024 High Similarity NPC29447
0.9024 High Similarity NPC473038
0.9024 High Similarity NPC11711
0.9012 High Similarity NPC69279
0.9012 High Similarity NPC83569
0.9 High Similarity NPC147066
0.8987 High Similarity NPC477371
0.8889 High Similarity NPC133391
0.8851 High Similarity NPC166906
0.8846 High Similarity NPC180886
0.8837 High Similarity NPC204341
0.8824 High Similarity NPC262043
0.878 High Similarity NPC477373
0.8765 High Similarity NPC278459
0.875 High Similarity NPC469995
0.875 High Similarity NPC318282
0.875 High Similarity NPC317586
0.875 High Similarity NPC173875
0.875 High Similarity NPC174948
0.875 High Similarity NPC470016
0.8706 High Similarity NPC242864
0.869 High Similarity NPC222613
0.869 High Similarity NPC475022
0.869 High Similarity NPC118648
0.8675 High Similarity NPC473246
0.8675 High Similarity NPC164577
0.8659 High Similarity NPC142253
0.8659 High Similarity NPC3511
0.8652 High Similarity NPC305483
0.8652 High Similarity NPC328162
0.8652 High Similarity NPC96859
0.8652 High Similarity NPC328371
0.8625 High Similarity NPC74410
0.8625 High Similarity NPC469996
0.8605 High Similarity NPC214387
0.8605 High Similarity NPC54689
0.8588 High Similarity NPC96496
0.8571 High Similarity NPC469948
0.8571 High Similarity NPC8571
0.8556 High Similarity NPC320306
0.8556 High Similarity NPC43747
0.8554 High Similarity NPC271784
0.8554 High Similarity NPC469561
0.8554 High Similarity NPC97913
0.8539 High Similarity NPC171395
0.8537 High Similarity NPC471898
0.8523 High Similarity NPC206810
0.8523 High Similarity NPC25750
0.8519 High Similarity NPC274996
0.8519 High Similarity NPC472490
0.8519 High Similarity NPC196827
0.8506 High Similarity NPC477149
0.8506 High Similarity NPC477147
0.85 High Similarity NPC165711
0.8488 Intermediate Similarity NPC471722
0.8471 Intermediate Similarity NPC474732
0.8471 Intermediate Similarity NPC55309
0.8471 Intermediate Similarity NPC474778
0.8471 Intermediate Similarity NPC31564
0.8471 Intermediate Similarity NPC28252
0.8471 Intermediate Similarity NPC145879
0.8471 Intermediate Similarity NPC474733
0.8471 Intermediate Similarity NPC72133
0.8471 Intermediate Similarity NPC155011
0.8462 Intermediate Similarity NPC235464
0.8462 Intermediate Similarity NPC166745
0.8462 Intermediate Similarity NPC197386
0.8452 Intermediate Similarity NPC214043
0.8452 Intermediate Similarity NPC472865
0.8452 Intermediate Similarity NPC87552
0.8452 Intermediate Similarity NPC85774
0.8452 Intermediate Similarity NPC96095
0.8444 Intermediate Similarity NPC456
0.8444 Intermediate Similarity NPC472941
0.8434 Intermediate Similarity NPC472239
0.8434 Intermediate Similarity NPC193347
0.8415 Intermediate Similarity NPC26139
0.8409 Intermediate Similarity NPC26888
0.8391 Intermediate Similarity NPC474889
0.8391 Intermediate Similarity NPC1015
0.8391 Intermediate Similarity NPC474570
0.8391 Intermediate Similarity NPC31985
0.8375 Intermediate Similarity NPC246445
0.8372 Intermediate Similarity NPC159046
0.8372 Intermediate Similarity NPC233836
0.8372 Intermediate Similarity NPC58063
0.8372 Intermediate Similarity NPC475740
0.8372 Intermediate Similarity NPC187376
0.837 Intermediate Similarity NPC327431
0.837 Intermediate Similarity NPC316964
0.8353 Intermediate Similarity NPC142649
0.8353 Intermediate Similarity NPC269638
0.8353 Intermediate Similarity NPC474537
0.8352 Intermediate Similarity NPC108078
0.8333 Intermediate Similarity NPC49019
0.8333 Intermediate Similarity NPC477852
0.8333 Intermediate Similarity NPC241156
0.8333 Intermediate Similarity NPC310470
0.8333 Intermediate Similarity NPC167103
0.8333 Intermediate Similarity NPC105803
0.8333 Intermediate Similarity NPC160817
0.8315 Intermediate Similarity NPC243866
0.8315 Intermediate Similarity NPC152897
0.8315 Intermediate Similarity NPC66429
0.8313 Intermediate Similarity NPC55869
0.8295 Intermediate Similarity NPC111585
0.8295 Intermediate Similarity NPC469400
0.8295 Intermediate Similarity NPC175628
0.8295 Intermediate Similarity NPC148414
0.8293 Intermediate Similarity NPC192744
0.8293 Intermediate Similarity NPC215843
0.8293 Intermediate Similarity NPC199595
0.8293 Intermediate Similarity NPC192329
0.8293 Intermediate Similarity NPC158846
0.828 Intermediate Similarity NPC163372
0.828 Intermediate Similarity NPC302537
0.828 Intermediate Similarity NPC99411
0.8276 Intermediate Similarity NPC131470
0.8276 Intermediate Similarity NPC117122
0.8276 Intermediate Similarity NPC143767
0.8272 Intermediate Similarity NPC66105
0.8272 Intermediate Similarity NPC212661
0.8272 Intermediate Similarity NPC471035
0.8261 Intermediate Similarity NPC471717
0.8256 Intermediate Similarity NPC186975
0.8256 Intermediate Similarity NPC472869
0.8256 Intermediate Similarity NPC212843
0.8242 Intermediate Similarity NPC125622
0.8242 Intermediate Similarity NPC42042
0.8242 Intermediate Similarity NPC95565
0.8235 Intermediate Similarity NPC165064
0.8235 Intermediate Similarity NPC59453
0.8235 Intermediate Similarity NPC19849
0.8235 Intermediate Similarity NPC237712
0.8235 Intermediate Similarity NPC472864
0.8235 Intermediate Similarity NPC221758
0.8235 Intermediate Similarity NPC144258
0.8222 Intermediate Similarity NPC184870
0.8214 Intermediate Similarity NPC69101
0.8214 Intermediate Similarity NPC472867
0.8214 Intermediate Similarity NPC296367
0.8214 Intermediate Similarity NPC251779
0.8214 Intermediate Similarity NPC100297
0.8214 Intermediate Similarity NPC240302
0.8202 Intermediate Similarity NPC154101
0.8202 Intermediate Similarity NPC297265
0.8202 Intermediate Similarity NPC23434
0.8193 Intermediate Similarity NPC472478
0.8193 Intermediate Similarity NPC108955
0.8193 Intermediate Similarity NPC37038
0.8193 Intermediate Similarity NPC2482
0.8191 Intermediate Similarity NPC204450
0.8191 Intermediate Similarity NPC119601
0.8191 Intermediate Similarity NPC308726
0.8191 Intermediate Similarity NPC195290
0.8182 Intermediate Similarity NPC26959
0.8182 Intermediate Similarity NPC84271
0.8182 Intermediate Similarity NPC102414
0.8182 Intermediate Similarity NPC77168
0.8182 Intermediate Similarity NPC477943
0.8182 Intermediate Similarity NPC86319
0.8182 Intermediate Similarity NPC268406
0.8182 Intermediate Similarity NPC474704
0.8182 Intermediate Similarity NPC186688
0.8182 Intermediate Similarity NPC112454
0.8182 Intermediate Similarity NPC305039
0.8182 Intermediate Similarity NPC275740
0.8182 Intermediate Similarity NPC477973
0.8182 Intermediate Similarity NPC475921
0.8172 Intermediate Similarity NPC51370
0.8172 Intermediate Similarity NPC287833
0.8171 Intermediate Similarity NPC321514
0.8171 Intermediate Similarity NPC110094
0.8171 Intermediate Similarity NPC260385
0.8171 Intermediate Similarity NPC189485
0.8171 Intermediate Similarity NPC30321
0.8171 Intermediate Similarity NPC280654
0.8161 Intermediate Similarity NPC236618
0.8161 Intermediate Similarity NPC93778
0.8161 Intermediate Similarity NPC142361
0.8161 Intermediate Similarity NPC136548
0.8161 Intermediate Similarity NPC312215
0.8161 Intermediate Similarity NPC99909
0.8161 Intermediate Similarity NPC167877
0.8161 Intermediate Similarity NPC474684
0.8161 Intermediate Similarity NPC128644

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470015 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8621 High Similarity NPD5284 Approved
0.8621 High Similarity NPD5281 Approved
0.8434 Intermediate Similarity NPD4221 Approved
0.8434 Intermediate Similarity NPD4223 Phase 3
0.8353 Intermediate Similarity NPD5329 Approved
0.8333 Intermediate Similarity NPD5695 Phase 3
0.8315 Intermediate Similarity NPD6399 Phase 3
0.8276 Intermediate Similarity NPD6672 Approved
0.8276 Intermediate Similarity NPD5737 Approved
0.8256 Intermediate Similarity NPD5690 Phase 2
0.8256 Intermediate Similarity NPD5280 Approved
0.8256 Intermediate Similarity NPD4694 Approved
0.8235 Intermediate Similarity NPD4786 Approved
0.8235 Intermediate Similarity NPD4197 Approved
0.8202 Intermediate Similarity NPD6050 Approved
0.8182 Intermediate Similarity NPD6904 Approved
0.8182 Intermediate Similarity NPD6080 Approved
0.8182 Intermediate Similarity NPD6673 Approved
0.8182 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.8171 Intermediate Similarity NPD3617 Approved
0.8152 Intermediate Similarity NPD6084 Phase 2
0.8152 Intermediate Similarity NPD6083 Phase 2
0.8125 Intermediate Similarity NPD5733 Approved
0.809 Intermediate Similarity NPD5692 Phase 3
0.8046 Intermediate Similarity NPD4689 Approved
0.8046 Intermediate Similarity NPD7146 Approved
0.8046 Intermediate Similarity NPD4138 Approved
0.8046 Intermediate Similarity NPD5330 Approved
0.8046 Intermediate Similarity NPD5279 Phase 3
0.8046 Intermediate Similarity NPD7334 Approved
0.8046 Intermediate Similarity NPD4688 Approved
0.8046 Intermediate Similarity NPD4693 Phase 3
0.8046 Intermediate Similarity NPD6684 Approved
0.8046 Intermediate Similarity NPD4690 Approved
0.8046 Intermediate Similarity NPD5205 Approved
0.8046 Intermediate Similarity NPD7521 Approved
0.8046 Intermediate Similarity NPD6409 Approved
0.8023 Intermediate Similarity NPD3133 Approved
0.8023 Intermediate Similarity NPD3665 Phase 1
0.8023 Intermediate Similarity NPD3666 Approved
0.8 Intermediate Similarity NPD3667 Approved
0.8 Intermediate Similarity NPD5694 Approved
0.7978 Intermediate Similarity NPD5328 Approved
0.7978 Intermediate Similarity NPD4753 Phase 2
0.7976 Intermediate Similarity NPD4695 Discontinued
0.7975 Intermediate Similarity NPD4747 Approved
0.7901 Intermediate Similarity NPD4687 Approved
0.7889 Intermediate Similarity NPD5207 Approved
0.7882 Intermediate Similarity NPD4692 Approved
0.7882 Intermediate Similarity NPD4139 Approved
0.7875 Intermediate Similarity NPD5276 Approved
0.7872 Intermediate Similarity NPD5696 Approved
0.7865 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7865 Intermediate Similarity NPD6903 Approved
0.7865 Intermediate Similarity NPD5208 Approved
0.7848 Intermediate Similarity NPD4137 Phase 3
0.7841 Intermediate Similarity NPD6098 Approved
0.7841 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7841 Intermediate Similarity NPD3618 Phase 1
0.7802 Intermediate Similarity NPD7515 Phase 2
0.7802 Intermediate Similarity NPD5693 Phase 1
0.7802 Intermediate Similarity NPD6079 Approved
0.775 Intermediate Similarity NPD4691 Approved
0.7742 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD4096 Approved
0.7667 Intermediate Similarity NPD4518 Approved
0.7647 Intermediate Similarity NPD4195 Approved
0.7634 Intermediate Similarity NPD7748 Approved
0.7614 Intermediate Similarity NPD3668 Phase 3
0.7604 Intermediate Similarity NPD6404 Discontinued
0.7576 Intermediate Similarity NPD5739 Approved
0.7576 Intermediate Similarity NPD7128 Approved
0.7576 Intermediate Similarity NPD6675 Approved
0.7576 Intermediate Similarity NPD6402 Approved
0.7553 Intermediate Similarity NPD4629 Approved
0.7553 Intermediate Similarity NPD5210 Approved
0.7553 Intermediate Similarity NPD5654 Approved
0.7528 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7527 Intermediate Similarity NPD5133 Approved
0.7527 Intermediate Similarity NPD4202 Approved
0.75 Intermediate Similarity NPD4788 Approved
0.7474 Intermediate Similarity NPD5221 Approved
0.7474 Intermediate Similarity NPD5222 Approved
0.7474 Intermediate Similarity NPD4697 Phase 3
0.7474 Intermediate Similarity NPD7614 Phase 1
0.7474 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD4058 Approved
0.7447 Intermediate Similarity NPD6001 Approved
0.7444 Intermediate Similarity NPD4519 Discontinued
0.7444 Intermediate Similarity NPD4623 Approved
0.7439 Intermediate Similarity NPD6081 Approved
0.7426 Intermediate Similarity NPD6899 Approved
0.7426 Intermediate Similarity NPD7320 Approved
0.7426 Intermediate Similarity NPD6881 Approved
0.7396 Intermediate Similarity NPD4755 Approved
0.7396 Intermediate Similarity NPD5959 Approved
0.7396 Intermediate Similarity NPD7902 Approved
0.7396 Intermediate Similarity NPD5173 Approved
0.7353 Intermediate Similarity NPD6373 Approved
0.7353 Intermediate Similarity NPD6372 Approved
0.7327 Intermediate Similarity NPD5701 Approved
0.7327 Intermediate Similarity NPD5697 Approved
0.7326 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD3621 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD7102 Approved
0.7282 Intermediate Similarity NPD6883 Approved
0.7282 Intermediate Similarity NPD7290 Approved
0.7262 Intermediate Similarity NPD4785 Approved
0.7262 Intermediate Similarity NPD4784 Approved
0.7255 Intermediate Similarity NPD6011 Approved
0.725 Intermediate Similarity NPD4224 Phase 2
0.7245 Intermediate Similarity NPD5285 Approved
0.7245 Intermediate Similarity NPD5286 Approved
0.7245 Intermediate Similarity NPD4700 Approved
0.7245 Intermediate Similarity NPD4696 Approved
0.7234 Intermediate Similarity NPD8035 Phase 2
0.7234 Intermediate Similarity NPD8034 Phase 2
0.7229 Intermediate Similarity NPD4243 Approved
0.7212 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD8130 Phase 1
0.7212 Intermediate Similarity NPD6869 Approved
0.7212 Intermediate Similarity NPD6617 Approved
0.7212 Intermediate Similarity NPD6847 Approved
0.7212 Intermediate Similarity NPD6649 Approved
0.7212 Intermediate Similarity NPD6650 Approved
0.72 Intermediate Similarity NPD6052 Approved
0.7184 Intermediate Similarity NPD6013 Approved
0.7184 Intermediate Similarity NPD6014 Approved
0.7184 Intermediate Similarity NPD6012 Approved
0.7176 Intermediate Similarity NPD6942 Approved
0.7176 Intermediate Similarity NPD7339 Approved
0.7174 Intermediate Similarity NPD3573 Approved
0.7172 Intermediate Similarity NPD5223 Approved
0.7143 Intermediate Similarity NPD7638 Approved
0.7143 Intermediate Similarity NPD8297 Approved
0.7143 Intermediate Similarity NPD6882 Approved
0.71 Intermediate Similarity NPD5225 Approved
0.71 Intermediate Similarity NPD5211 Phase 2
0.71 Intermediate Similarity NPD5091 Approved
0.71 Intermediate Similarity NPD4633 Approved
0.71 Intermediate Similarity NPD5224 Approved
0.71 Intermediate Similarity NPD5226 Approved
0.7083 Intermediate Similarity NPD7900 Approved
0.7083 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD7640 Approved
0.7071 Intermediate Similarity NPD7639 Approved
0.7059 Intermediate Similarity NPD6008 Approved
0.7053 Intermediate Similarity NPD6411 Approved
0.7037 Intermediate Similarity NPD7115 Discovery
0.7037 Intermediate Similarity NPD7331 Phase 2
0.703 Intermediate Similarity NPD5174 Approved
0.703 Intermediate Similarity NPD5175 Approved
0.703 Intermediate Similarity NPD4754 Approved
0.7 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.699 Remote Similarity NPD6412 Phase 2
0.699 Remote Similarity NPD6614 Approved
0.6961 Remote Similarity NPD5141 Approved
0.6957 Remote Similarity NPD5363 Approved
0.6947 Remote Similarity NPD5785 Approved
0.6944 Remote Similarity NPD6868 Approved
0.6939 Remote Similarity NPD7732 Phase 3
0.6923 Remote Similarity NPD3527 Clinical (unspecified phase)
0.6923 Remote Similarity NPD5362 Discontinued
0.6916 Remote Similarity NPD4632 Approved
0.6914 Remote Similarity NPD7341 Phase 2
0.6897 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6897 Remote Similarity NPD6117 Approved
0.6893 Remote Similarity NPD4767 Approved
0.6893 Remote Similarity NPD4768 Approved
0.6889 Remote Similarity NPD5369 Approved
0.6867 Remote Similarity NPD5361 Clinical (unspecified phase)
0.6867 Remote Similarity NPD5360 Phase 3
0.686 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6842 Remote Similarity NPD6101 Approved
0.6842 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6818 Remote Similarity NPD6335 Approved
0.6818 Remote Similarity NPD6116 Phase 1
0.6813 Remote Similarity NPD4270 Approved
0.6813 Remote Similarity NPD4269 Approved
0.6789 Remote Similarity NPD6274 Approved
0.6782 Remote Similarity NPD5275 Approved
0.6782 Remote Similarity NPD4190 Phase 3
0.6778 Remote Similarity NPD5368 Approved
0.6778 Remote Similarity NPD7525 Registered
0.6778 Remote Similarity NPD8259 Clinical (unspecified phase)
0.6762 Remote Similarity NPD4730 Approved
0.6762 Remote Similarity NPD5168 Approved
0.6762 Remote Similarity NPD4729 Approved
0.6762 Remote Similarity NPD5128 Approved
0.6757 Remote Similarity NPD7100 Approved
0.6757 Remote Similarity NPD7101 Approved
0.6742 Remote Similarity NPD6697 Approved
0.6742 Remote Similarity NPD6118 Approved
0.6742 Remote Similarity NPD6114 Approved
0.6742 Remote Similarity NPD6115 Approved
0.6727 Remote Similarity NPD6009 Approved
0.6727 Remote Similarity NPD6317 Approved
0.6707 Remote Similarity NPD3171 Clinical (unspecified phase)
0.6706 Remote Similarity NPD4789 Approved
0.6701 Remote Similarity NPD7637 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data